|
Author, yr (Ref)
|
Country
|
Study design
|
PCOS diagnostic criteria
|
Cancer diagnostic criteria
|
PCOS group characteristics
|
Control group characteristics
|
Outcome of interest
|
Adjustments
|
Unadjusted OR
(95% CI)
|
Quality assessment
|
Ding
et al.
, 2018 (11)
|
Taiwan |
Cohort |
ICD-9-CM1 Code 256.4 |
ICD-9-CM Code 174 and 175 |
N = 8155 Age = 27.7 (7.0) BMI = Not reported |
N = 32620 Age = 27.5 (7.9) BMI = Not reported |
Endometrial, ovarian, and breast cancer |
Age, comorbidities |
Endometrial cancer OR: 14.685 (4.096, 52.650) ovarian cancer OR:1.60 (0.62, 4.13) breast cancer OR:0.80 (0.47, 1.35) |
High |
Harris
et al.
, 2017 (27)
|
US |
Case-control |
Not reported |
Not reported |
N = 78 Age and BMI not reported for case |
N = 4063 Age and BMI not reported for control |
Ovarian cancer |
Age, study, parity, oral contraceptive use, center, tubal ligation, family history of ovarian cancer |
1.16 (0.74, 1.82) |
High |
Kim
et al.
, 2016 (16)
|
US |
Case-control |
Rotterdam criteria |
Not reported |
N = 67 Age = 53.8
12.2 BMI = 27.4
6.2 |
N = 2951 Age = 58.0
12.8 BMI = 26.5
5.7 |
Breast cancer |
Age, physical activity |
1.30 (0.80, 2.12) |
High |
Shen
et al.
, 2015 (15)
|
Taiwan |
Cohort |
NIH4 or ICD-9-CM |
ICD-9-CM Code 174 |
N = 3566 Age = 27.04 (22.66-32.10) BMI = Not reported |
N = 14264 Age = 27.05 (22.72-32.10) BMI = Not reported |
Endometrial, ovarian, and breast cancer |
Age, hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, congestive heart disease, cerebrovascular disease, chronic pulmonary disease, urbanization, and income |
Endometrial cancer OR: 10.013 (1.942, 51.629) ovarian cancer OR: 0.89 (0.19, 4.12) breast cancer OR: 1.87 (0.99, 3.53) |
High |
Ghasemi
et al.
, 2012 (29)
|
Iran |
Case-control |
Rotterdam |
Histologically confirmed |
N = 27 Age = 30-51 BMI not reported |
N = 305 Age = 30-51 BMI not reported |
Breast cancer |
None |
0.67 (0.30, 1.48) |
Moderate |
Bodmer
et al.
, 2011 (33)
|
UK |
Case-control |
Used diagnosis from GPRD |
Based on evidence of cancer-related therapy |
N = 28 Age = 61.2
13.1 |
N = 10753 Age = 61.2
13.1 |
Ovarian cancer |
BMI, smoking, prior, use of hormones, history o hysterectomy, endometriosis |
1.55 (0.63, 3.84) |
Moderate |
Fearnley
et al.
, 2010 (28)
|
Australia |
Case-control |
Not reported |
Histologically confirmed |
N = 32 Age
50 yr BMI = not reported |
N = 522 Age
50 yr BMI = Not reported |
Endometrial cancer |
BMI |
3.638 (1.761, 7.515) |
High |
Zuchetto
et al.
, 2009 (34)
|
Italy |
Case-control |
Not reported |
Histologically confirmed |
N = 68 Age = 18-79 BMI not reported |
N = 1287 Age = 18-79 BMI not reported |
Endometrial cancer |
Period of interview, BMI, age at menarche, age at menopause, parity, and oral contraceptive use |
1.171 (0.706, 1.943) |
High |
Olsen
et al.
, 2008 (30)
|
Australia |
Case-control |
Not reported |
Histologically confirmed |
N = 52 Age = 18-79 BMI not reported |
N = 3047 Age = 18-79 BMI not reported |
Ovarian cancer |
Age, education, parity, hormonal contraceptive use, and BMI |
1.15 (0.66, 1.99) |
High |
Wild
et al.
, 2000 (26)
|
UK |
Cohort |
Laparoscopic |
ICD-7 and ICD-8 |
N = 319 Age = 38-98 BMI = 27.1 |
N = 1060 Age = 38-98 BMI = 26.2 |
Endometrial and breast cancer |
BMI |
Endometrial cancer OR: 5.923 (1.721, 20.365) breast cancer OR: 1.21 (0.63, 2.31) |
High |
Anderson
et al.
, 1997 (17)
|
USA |
Cohort |
Not reported |
ICD codes 174.0-174.9 |
N = 472 Age = 55-69 BMI = 27.2
0.23 |
N = 34363 Age = 55-69 BMI = 27
0.03 |
Breast cancer |
Age, age at menarche, age at first pregnancy, parity, oral contraceptive use, hormone replacement therapy, BMI, waist to hip ratio, benign breast disease, and family history of breast cancer |
1.18 (0.69, 2.01) |
Moderate |
Talamini
et al.
, 1997 (32)
|
Italy |
Case-control |
Not reported |
Histologically confirmed |
N = 30 Age = 20-74 BMI not reported |
N = 5127 Age = 20-74 BMI not reported |
Breast cancer |
Age at menarche |
0.88 (0.43, 1.81) |
Moderate |
Schildkraut
et al.
, 1996 (13)
|
USA |
Case-control |
Not reported |
Histologically confirmed |
N = 31 Age = 20-54 BMI not reported |
N = 4526 Age = 20-54 BMI not reported |
Ovarian cancer |
Age, parity, and oral contraceptive use |
2.52 (1.08, 5.89) |
High |
Escobedo
et al.
, 1991 (31)
|
Georgia |
Case-control |
Not reported |
Histologically confirmed |
N = 30 Age = 20-54 BMI not reported |
N = 3593 Age = 20-54 BMI not reported |
Endometrial cancer |
Age |
3.757 (1.747, 8.081) |
Moderate |
PCOS: Polycystic ovary syndrome, BMI: Body mass index, N: Number, OR: Odds ratio, ICD: International classification of disease, NIH: National institute of health, ICD-9-CM: International classification of diseases, ninth revision, clinical modification, GPRD: General practice research database |